Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Cancer Metastatic × Capecitabine × Clear all

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 6 Stomach Neoplasms 4 Colorectal Neoplasms 4 Breast Neoplasms 4 Esophageal Neoplasms 3 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colonic Neoplasms 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Oesophagogastric Cancer 1 Neuroendocrine Tumors 1 Mid-low Rectal Cancer 1 Metastatic Breast Cancer in the Brain 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Liver Metastases of Colorectal Cancer 1 Immunotherapy 1 HER2 Positive Metastatic Breast Cancer 1 Cholangiocarcinoma 1 Breast Cancer Metastatic 1 Advanced Breast Cancer 1

Interventions

Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04350021 2024-01-17

METRO

Vastra Gotaland Region

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡